CDC2 Protein Kinase, antagonists & inhibitors
- Name
- CDC2 Protein Kinase, antagonists & inhibitors
- Accession Number
- DBCAT001612
- Description
Not Available
- Drugs
Drug Drug Description Purvalanol A Not Available AG-24322 AG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin. - Drugs & Drug Targets
Drug Target Type Purvalanol A Proto-oncogene tyrosine-protein kinase Src target Purvalanol A Casein kinase I isoform gamma-3 target Purvalanol A Ribosomal protein S6 kinase alpha-1 target